0000728889-17-000247.txt : 20170206 0000728889-17-000247.hdr.sgml : 20170206 20170206164959 ACCESSION NUMBER: 0000728889-17-000247 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170206 DATE AS OF CHANGE: 20170206 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-38071 FILM NUMBER: 17576140 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: OppenheimerFunds, Inc. CENTRAL INDEX KEY: 0000728889 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 000000000 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 225 LIBERTY STREET CITY: NEW YORK STATE: NY ZIP: 10281-1008 BUSINESS PHONE: 212-323-0200 MAIL ADDRESS: STREET 1: 225 LIBERTY STREET CITY: NEW YORK STATE: NY ZIP: 10281-1008 FORMER COMPANY: FORMER CONFORMED NAME: OPPENHEIMER FUNDS INC DATE OF NAME CHANGE: 20020227 FORMER COMPANY: FORMER CONFORMED NAME: OPPENHEIMER MANAGEMENT CORP DATE OF NAME CHANGE: 19940131 SC 13G/A 1 repligencorp1.htm SCHEDULE 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

REPLIGEN CORP

(Name of Issuer)
 

COMMON STOCK

(Title of Class of Securities)
 

759916109

(CUSIP Number)
 

12/31/2016

(Date of Event Which Requires Filing of this Statement)



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

CUSIP No.: 759916109
1. Names of Reporting Persons:
OppenheimerFunds, Inc.
IRS Identification No: 13-2527171
2. Check the Appropriate Box if a Member of a Group (See Instructions):
Joint Filing
3.
SEC Use Only
4. Citizenship or Place of Organization:
Colorado
Number of Shares Beneficially Owned by Each Reporting Person With 5.  Sole Voting Power: 0

6.  Shared Voting Power: 1,940,970

7.  Sole Dispositive Power: 0

8.  Shared Dispositive Power: 1,940,970

9. Aggregate Amount Beneficially Owned by Each Reporting Person:
1,940,970 (beneficial ownership disclaimed pursuant to Rule 13d-4 of the Exchange Act of 1934)
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[  ]

11. Percent of Class Represented by Amount in Row (9):
5.74

12. Type of Reporting Person (See Instructions):
IA

 

Item:
1(a) Name of Issuer:
REPLIGEN CORP

1(b) Address of Issuer's Principal Executive Offices:
41 SEYON STREET
BUILDING 1, SUITE 100
WALTHAM, MA 02453

2(a) Name of Person Filing:
OppenheimerFunds, Inc.

2(b) Address of Principal Business Office or, if none, Residence:
225 Liberty Street
New York, NY 10281

2(c) Citizenship:
Colorado

2(d) Title of Class of Securities:
COMMON STOCK

2(e) CUSIP Number:
759916109

3 If this statement is filed pursuant to §240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
[X] An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E)

4(a) Amount beneficially owned:
1,940,970
(beneficial ownership disclaimed pursuant to Rule 13d-4 of the Exchange Act of 1934)

4(b) Percent of class:
5.74

4(c) Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
1,940,970
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
1,940,970
5 Ownership of Five Percent or Less of a Class: [ ]
OppenheimerFunds, Inc.

6 Ownership of More than Five Percent on Behalf of Another Person.:
N/A

7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:
N/A

8 Identification and Classification of Members of the Group:
N/A

9 Notice of Dissolution of Group:
N/A

10 Certification:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

2/06/2017

Date
 
 

/s/ Mary Ann Picciotto

Signature
 
 

Mary Ann Picciotto, Sr. Vice President and Chief Compliance Officer

Name/Title

 

If you have questions please contact Judith Gottlieb at (212) 323-4858 or by email at jgottlieb@ofiglobal.com